Live from the NIH registry
Studies recruiting near Toledo right now
Top 25 of 208 recruiting studies, sorted by proximity — each links to its official registry page
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
Non-small Cell Lung Cancer (NSCLC), Colorectal Cancer (CRC)
Phase 1, Phase 2
Interventional 754 participants sought
Taylor Cancer Research Center — Maumee, Ohio (7.9 mi)
· Sponsor: Revolution Medicines, Inc.
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
B Acute Lymphoblastic Leukemia
Phase 2
Interventional 222 participants sought
ProMedica Toledo Hospital/Russell J Ebeid Children's Hospital — Toledo, Ohio (1.4 mi)
· Sponsor: National Cancer Institute (NCI)
A Clinical Trial to Evaluate EDV Nanocell Therapy With Gemcitabine and Nab-paclitaxel in Pancreatic Cancer
Pancreatic Cancer, Metastatic, PDAC - Pancreatic Ductal Adenocarcinoma
Phase 1, Phase 2
Interventional 144 participants sought
Taylor Cancer Center — Maumee, Ohio (7.9 mi)
· Sponsor: Engeneic Pty Limited
Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma
Smoldering Plasma Cell Myeloma
Phase 3
Interventional 288 participants sought
Mercy Health - Saint Vincent Hospital — Toledo, Ohio (1.4 mi)
· Sponsor: ECOG-ACRIN Cancer Research Group
Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer, the PROBE Trial
Metastatic Clear Cell Renal Cell Carcinoma, Metastatic Renal Cell Carcinoma
Phase 3
Interventional 364 participants sought
University of Toledo — Toledo, Ohio (1.4 mi)
· Sponsor: SWOG Cancer Research Network
Mosaic Mitral Valve: Long-Term Outcomes in Patients Under 65
Valve Disease, Heart, Valve Replacement
N/A
Observational 300 participants sought
ProMedica Toledo Hospital — Toledo, Ohio (1.4 mi)
· Sponsor: Michael Moront
Proximal Internal Carotid Artery Acute Stroke Secondary to Tandem or Local Occlusion Thrombectomy Trial
Acute Ischemic Stroke
Phase 3
Interventional 404 participants sought
Mercy Health St. Vincent Medical Center — Toledo, Ohio (1.4 mi)
· Sponsor: Mercy Health Ohio
A Study Evaluating Disease Characteristics and Outcomes in Participants With Asthma in Routine Clinical Practice
Asthma
N/A
Observational 2,500 participants sought
Toledo Institute of Clinical Research Inc - Site Number: 840105 — Toledo, Ohio (1.4 mi)
· Sponsor: Sanofi
ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack
Cardiovascular Risk, Acute Myocardial Infarction (AMI)
Phase 3
Interventional 10,000 participants sought
ProMedica — Toledo, Ohio (1.4 mi)
· Sponsor: Novo Nordisk A/S
Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
Triple-Negative Breast Cancer
Phase 3
Interventional 1,530 participants sought
Taylor Cancer Research Center ( Site 9500) — Maumee, Ohio (7.9 mi)
· Sponsor: Merck Sharp & Dohme LLC
A Randomized, Double-Blind, Placebo-Controlled Trial on Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Combination in Participants 12 Years and Older With Asthma
Asthma
Phase 3
Interventional 724 participants sought
Teva Investigational Site 12063 — Toledo, Ohio (1.4 mi)
· Sponsor: Teva Branded Pharmaceutical Products R&D LLC
JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort C: Bevacizumab
Acute Respiratory Distress Syndrome (ARDS), ARDS
Phase 2
Interventional 200 participants sought
Mercy Health - St. Vincent Medical Center — Toledo, Ohio (1.4 mi)
· Sponsor: PPD Development, LP
Alleviant ALLAY-HFrEF Study
Heart Failure
N/A
Interventional 350 participants sought
ProMedica Toledo Hospital — Toledo, Ohio (1.4 mi)
· Sponsor: Alleviant Medical, Inc.
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
COPD (Chronic Obstructive Pulmonary Disease)
Phase 3
Interventional 5,000 participants sought
Research Site — Toledo, Ohio (1.4 mi)
· Sponsor: AstraZeneca
DESTINY-PANTUMOUR04
Adenocarcinoma (NOS), Anal Cancer
N/A
Observational 100 participants sought
Research Site — Maumee, Ohio (7.9 mi)
· Sponsor: AstraZeneca
Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
Arrhythmia, Bradycardia
N/A
Observational 20,000 participants sought
Research site — Toledo, Ohio (1.4 mi)
· Sponsor: Medtronic
A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT
Anaplastic Kidney Wilms Tumor, Recurrent Kidney Wilms Tumor
Phase 2
Interventional 256 participants sought
ProMedica Toledo Hospital/Russell J Ebeid Children's Hospital — Toledo, Ohio (1.4 mi)
· Sponsor: Children's Oncology Group
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia
Phase 1, Phase 2
Interventional 960 participants sought
ProMedica Toledo Hospital/Russell J Ebeid Children's Hospital — Toledo, Ohio (1.4 mi)
· Sponsor: PedAL BCU, LLC
Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer
Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8
Phase 3
Interventional 3,680 participants sought
ProMedica Flower Hospital — Sylvania, Ohio (7.7 mi)
· Sponsor: National Cancer Institute (NCI)
HP-211 Safety and Proof of Concept Dose Ranging Study in Patients With Type 2 Diabetes
Type 2 Diabetes
Phase 2
Interventional 300 participants sought
Advanced Medical Research — Maumee, Ohio (7.9 mi)
· Sponsor: Housey Healthcare ULC
TTX-080 HLA-G Antagonist in Subjects With Advanced Cancers
Cancer
Phase 1
Interventional 240 participants sought
The University of Toledo — Toledo, Ohio (1.4 mi)
· Sponsor: Tizona Therapeutics, Inc
A Study to Identify and Characterize Patients With Type 2 Diabetes Mellitus for Possible Participation in Ongoing or Future Type 2 Diabetes Mellitus Clinical Studies
Type 2 Diabetes
N/A
Observational 2,150 participants sought
Research Site — Maumee, Ohio (7.9 mi)
· Sponsor: AstraZeneca
Testing the Combination of Venetoclax and Rituximab, in Comparison to the Usual Treatment (Ibrutinib Plus Rituximab or Zanubrutinib Alone) for Waldenstrom's Macroglobulinemia/Lymphoplasmacytic Lymphoma
Lymphoplasmacytic Lymphoma, Waldenstrom Macroglobulinemia
Phase 2
Interventional 92 participants sought
Mercy Health - Saint Vincent Hospital — Toledo, Ohio (1.4 mi)
· Sponsor: National Cancer Institute (NCI)
Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen
Viral Lung Infection and Acute Respiratory Failure
Phase 3
Interventional 3,527 participants sought
Research Site — Toledo, Ohio (1.4 mi)
· Sponsor: AstraZeneca
A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma
High Grade Osteosarcoma, Localized Osteosarcoma
Phase 2, Phase 3
Interventional 1,122 participants sought
ProMedica Toledo Hospital/Russell J Ebeid Children's Hospital — Toledo, Ohio (1.4 mi)
· Sponsor: National Cancer Institute (NCI)